(Q35188400)

7 August 2017

1 reference

title

Mechanistic models for myelosuppression (English)

1 reference

7 August 2017

2

Mats O Karlsson

1 reference

7 August 2017

Lena E Friberg

1

1 reference

7 August 2017

publication date

1 May 2003

1 reference

Investigational New Drugs

7 August 2017

published in

1 reference

7 August 2017

volume

21

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

183-194

1 reference

Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.

7 August 2017

cites work

1 reference

12 December 2020

Nature of the hemopoietic stem cell compartment and its proliferative potential

1 reference

12 December 2020

Human CD34(+) bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma

1 reference

12 December 2020

Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics

1 reference

12 December 2020

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole

1 reference

12 December 2020

Pharmacodynamic modeling of the entire time course of leukopenia after a 3-hour infusion of paclitaxel

1 reference

12 December 2020

Therapeutic relevance of pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats

1 reference

12 December 2020

Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule

1 reference

12 December 2020

A mathematical model of neutrophil production and control in normal man.

1 reference

12 December 2020

Cyclical neutropenia and the peripheral control of white blood cell production.

1 reference

12 December 2020

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1 reference

12 December 2020

Blood transit and recirculation kinetics of lymphocyte subsets in normal rats

1 reference

12 December 2020

Models of schedule dependent haematological toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC)

1 reference

12 December 2020

Experimental chemotherapy and concepts related to the cell cycle

1 reference

12 December 2020

Simulation of murine granulopoiesis.

1 reference

12 December 2020

A concept of hemopoietic regulation and its biomathematical realization

1 reference

12 December 2020

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin

1 reference

12 December 2020

Kinetic model of a bone-marrow stem-cell population

1 reference

12 December 2020

Pharmacological analysis of etoposide in elderly patients with lung cancer

1 reference

12 December 2020

Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability.

1 reference

12 December 2020

Granulocyte colony-stimulating factor and its receptor

1 reference

12 December 2020

Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers

1 reference

12 December 2020

Developmental potential and dynamic behavior of hematopoietic stem cells.

1 reference

12 December 2020

Clinical and pharmacologic analysis of hyperfractionated daily oral etoposide

1 reference

12 December 2020

A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression

1 reference

12 December 2020

Potential roles for preclinical pharmacology in phase I clinical trials

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Model of chemotherapy-induced myelosuppression with parameter consistency across drugs

1 reference

12 December 2020

Interferon‐γ and tumor necrosis factor‐α suppress both early and late stages of hematopoiesis and induce programmed cell death

1 reference

12 December 2020

Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

1 reference

12 December 2020

Assessment of myelotoxic effects of chemotherapy from early leukopenic response: Application of a mathematical model for granulopoiesis

1 reference

12 December 2020

LEUKOKINETIC STUDIES. II. A METHOD FOR LABELING GRANULOCYTES IN VITRO WITH RADIOACTIVE DIISOPROPYLFLUOROPHOSPHATE (DFP)

1 reference

12 December 2020

Circadian cancer therapy

1 reference

12 December 2020

Neutrophil kinetics in man

1 reference

12 December 2020

The role of polymorphonuclear neutrophils (PMNs) in clearance of granulocyte colony-stimulating factor (G-CSF) in vivo and in vitro.

1 reference

12 December 2020

Pharmacologically guided phase I clinical trials based upon preclinical drug development

1 reference

12 December 2020

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

1 reference

12 December 2020

Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteers.

1 reference

12 December 2020

A population model for the leukopenic effect of etoposide

1 reference

12 December 2020

Computer simulation of granulopoiesis: normal and impaired granulopoiesis

1 reference

12 December 2020

THE KINETICS OF GRANULOPOIESIS IN NORMAL MAN.

1 reference

12 December 2020

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities

1 reference

12 December 2020

Basic pharmacodynamic models for agents that alter production of natural cells.

1 reference

12 December 2020

Kinetics of the formed elements of human blood

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

Pharmacodynamic model of topotecan-induced time course of neutropenia

1 reference

12 December 2020

The hematopoietic and mature blood cells of the rat: their morphology and the kinetics of circulating leukocytes in control rats

1 reference

12 December 2020

A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement.

1 reference

12 December 2020

Leukokinetic studies. III. The distribution of granulocytes in the blood of normal subjects

1 reference

12 December 2020

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

1 reference

12 December 2020

Toxicity of cytostatic drugs to normal bone marrow cells in vitro

1 reference

12 December 2020

GRANULOCYTOPOIESIS. II. EMERGENCE AND PATTERN OF LABELING OF NEUTROPHILIC GRANULOCYTES IN HUMANS

1 reference

12 December 2020

A simple model of a steady state differentiating cell system

1 reference

12 December 2020

Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis.

1 reference

12 December 2020

A mathematical model of the chemotherapeutic treatment of acute myeloblastic leukemia

1 reference

12 December 2020

Mathematical model of granulocytopoiesis and chronic myelogenous leukemia.

1 reference

12 December 2020

Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow

1 reference

12 December 2020

Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agents

1 reference

12 December 2020

Combining physiologic models and symbolic methods to interpret time-varying patient data

1 reference

12 December 2020

A comprehensive modeling procedure for the human granulopoietic system: over-all view and summary of data

1 reference

12 December 2020

A mathematical model of canine granulocytopoiesis

1 reference

12 December 2020

Pharmacodynamic analysis of hematologic profiles.

1 reference

12 December 2020

Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD model.

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic modeling in drug development

1 reference

12 December 2020

Parameterization of in vivo leukemic cell populations

1 reference

12 December 2020

Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model.

1 reference

12 December 2020

Granulocyte transit from bone marrow to blood

1 reference

12 December 2020

Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil.

1 reference

12 December 2020

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

1 reference

12 December 2020

Indirect-response model for the time course of leukopenia with anticancer drugs.

1 reference

12 December 2020

Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts

1 reference

12 December 2020

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

1 reference

12 December 2020

Modeling complex neutrophil dynamics in the grey collie.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023573429626

1 reference

Dimensions Publication ID

7 August 2017

1017373225

0 references

1 reference